Drawing for Serial No. 97566785

USPTO serial 97566785

Serial No. 97566785

Reviewed by CopyMark Law Group

Reg. 7182177Status 700Registered
Filing date
Status date
Registration date
Oct 3, 2023
Examiner
JOHNSON, CLINTON J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 97566785?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Justin Johanson

JUSTIN JOHANSON RLAS21920 E. PEGASUS PARKWAYQUEEN CREEK, AZ 85142UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Consultancy in the field of artificial intelligence technology; Platform as a service (PAAS) featuring computer software platforms for using data, analytics, and artificial intelligence to deliver understandable data to quality and safety professionals; Platform as a service (PAAS) featuring computer software platforms for applying artificial intelligence to raw data; Platform as a service (PAAS) featuring computer software platforms for providing regulatory and quality intelligence to FDA-regulated industries; Platform as a service (PAAS) featuring computer software platforms for providing real-time data from data by tracking inspections, enforcement actions, regulatory publications, and merger and acquisition activity; Platform as a service (PAAS) featuring computer software platforms for assimilating, normalizing, and categorizing unstructured data; Platform as a service (PAAS) featuring computer software platforms for applying machine learning, natural language processing, and artificial intelligence to raw data; Platform as a service (PAAS) featuring computer software platforms for providing integrated data, intelligent visualization, and data workflow; Platform as a service (PAAS) featuring computer software platforms for analyzing and transforming data points and signals from health agencies into meaningful answers and insights that reduce regulatory and compliance risk; Platform as a service (PAAS) featuring computer software platforms for applying artificial intelligence to large and disparate government data sets; Providing a web site featuring technology that enables users to use data, analytics, and artificial intelligence to deliver understandable data to quality and safety professionals; Providing a web site featuring technology that enables users to apply artificial intelligence to raw data; Providing a web site featuring technology that enables users to access and view regulatory and quality intelligence data related to FDA-regulated industries; Providing a web site featuring technology that enables users to access, create, filter, and view real-time data from data by tracking inspections, enforcement actions, regulatory publications, and merger and acquisition activity; Providing a web site featuring technology that enables users to access, create, filter, and view data that has been assimilated, normalized, and categorized from unstructured data; Providing a web site featuring technology that enables users to access, create, filter, and view integrated data, intelligent visualization, and data workflow; Providing a web site featuring technology that enables users to access, create, filter, and view data that has been analyzed and processed by applying artificial intelligence to government data sets; Software as a service (SAAS) services featuring software for using data, analytics, and artificial intelligence to deliver understandable data to quality and safety professionals; Software as a service (SAAS) services featuring software for applying artificial intelligence to large and disparate government data sets; Software as a service (SAAS) services featuring software for analyzing and transforming data points and signals from health agencies into meaningful answers and insights that reduce regulatory and compliance risk; Software as a service (SAAS) services featuring software for providing integrated data, intelligent visualization, and data workflow; Software as a service (SAAS) services featuring software for applying machine learning, natural language processing, and artificial intelligence to raw data; Software as a service (SAAS) services featuring software for applying artificial intelligence to raw data; Software as a service (SAAS) services featuring software for providing regulatory and quality intelligence to FDA-regulated industries; Software as a service (SAAS) services featuring software for providing real-time data from data by tracking inspections, enforcement actions, regulatory publications, and merger and acquisition activity; Software as a service (SAAS) services featuring software for assimilating, normalizing, and categorizing unstructured data; Computer programming services for data processing; Software as a service (SAAS) services featuring software using artificial intelligence for using data, analytics, and artificial intelligence to deliver understandable data to quality and safety professionals; Software as a service (SAAS) services featuring software using artificial intelligence for applying artificial intelligence to raw data; Software as a service (SAAS) services featuring software using artificial intelligence for providing regulatory and quality intelligence to FDA-regulated industries; Software as a service (SAAS) services featuring software using artificial intelligence for providing real-time data from data by tracking inspections, enforcement actions, regulatory publications, and merger and acquisition activity; Software as a service (SAAS) services featuring software using artificial intelligence for assimilating, normalizing, and categorizing unstructured data; Software as a service (SAAS) services featuring software using artificial intelligence for applying machine learning, natural language processing, and artificial intelligence to raw data; Software as a service (SAAS) services featuring software using artificial intelligence for providing integrated data, intelligent visualization, and data workflow; Software as a service (SAAS) services featuring software using artificial intelligence for analyzing and transforming data points and signals from health agencies into meaningful answers and insights that reduce regulatory and compliance risk; Software as a service (SAAS) services featuring software using artificial intelligence for applying artificial intelligence to large and disparate government data sets; Software engineering services for data processing; Technology consultation in the field of artificial intelligenceACTIVEJan 1, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 3, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 13, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 13, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 13, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 13, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 13, 2023DOCKASSIGNED TO EXAMINER—
Sep 15, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 14, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 30, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance